- Home
- NAAS vs EVGN Comparison
NAAS vs EVGN Comparison
Compare NAAS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- EVGN
- Stock Information
- Founded
- NAAS 2019
- EVGN 1999
- Country
- NAAS China
- EVGN Israel
- Employees
- NAAS N/A
- EVGN N/A
- Industry
- NAAS Other Specialty Stores
- EVGN Agricultural Chemicals
- Sector
- NAAS Consumer Discretionary
- EVGN Industrials
- Exchange
- NAAS Nasdaq
- EVGN Nasdaq
- Market Cap
- NAAS 8.3M
- EVGN 9.7M
- IPO Year
- NAAS 2017
- EVGN N/A
- Fundamental
- Price
- NAAS $1.23
- EVGN $1.13
- Analyst Decision
- NAAS
- EVGN Strong Buy
- Analyst Count
- NAAS 0
- EVGN 1
- Target Price
- NAAS N/A
- EVGN $12.00
- AVG Volume (30 Days)
- NAAS 1.3M
- EVGN 1.1M
- Earning Date
- NAAS 05-20-2025
- EVGN 05-21-2025
- Dividend Yield
- NAAS N/A
- EVGN N/A
- EPS Growth
- NAAS N/A
- EVGN N/A
- EPS
- NAAS N/A
- EVGN N/A
- Revenue
- NAAS $43,258,393.00
- EVGN $8,511,000.00
- Revenue This Year
- NAAS $19.53
- EVGN $68.62
- Revenue Next Year
- NAAS $151.36
- EVGN $66.92
- P/E Ratio
- NAAS N/A
- EVGN N/A
- Revenue Growth
- NAAS 50.34
- EVGN 50.90
- 52 Week Low
- NAAS $1.23
- EVGN $0.95
- 52 Week High
- NAAS $76.80
- EVGN $9.00
- Technical
- Relative Strength Index (RSI)
- NAAS 27.23
- EVGN 46.73
- Support Level
- NAAS $1.18
- EVGN $1.09
- Resistance Level
- NAAS $3.49
- EVGN $1.22
- Average True Range (ATR)
- NAAS 0.28
- EVGN 0.09
- MACD
- NAAS 0.04
- EVGN 0.01
- Stochastic Oscillator
- NAAS 2.16
- EVGN 43.42
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.